Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

LB PHARMACEUTICALS INC Director's Dealing 2025

Nov 19, 2025

33183_dirs_2025-11-18_a5664c9b-129e-4c1b-a829-39705278928f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: LB PHARMACEUTICALS INC (LBRX)
CIK: 0001691082
Period of Report: 2025-11-10

Reporting Person: Pai Panandiker Kaya Kamlesh (N/A)

More from LB PHARMACEUTICALS INC

Interim / Quarterly Report 2026
May 12
Interim / Quarterly Report 2026
May 12
Report Publication Announcement 2026
May 12
Proxy Solicitation & Information Statement 2026
Apr 23
Capital/Financing Update 2026
Apr 14
Capital/Financing Update 2026
Apr 6
Regulatory Filings 2026
Mar 26
Major Shareholding Notification 2026
Feb 10
Director's Dealing 2026
Feb 10
Capital/Financing Update 2026
Feb 5
View all filings →